Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-01-531901
Filing Date
2001-09-10
Accepted
2001-09-10 00:00:00
Documents
8
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2058681z10-k.txt 10-K 205478
3 EXHIBIT 10(HHH) a2058681zex-10_hhh.txt EX-10.(HHH) 11092
4 EXHIBIT 10(JJJ) a2058681zex-10_jjj.txt EX-10.(JJJ) 4549
5 EXHIBIT 10(KKK) a2058681zex-10_kkk.txt EX-10.(KKK) 6821
6 EXHIBIT 10(LLL) a2058681zex-10_lll.txt EX-10.(LLL) 11776
7 EXHIBIT 10(MMM) a2058681zex-10_mmm.txt EX-10.(MMM) 2295
8 EXHIBIT 21 a2058681zex-21.txt EX-21 469
9 EXHIBIT 23.1 a2058681zex-23_1.txt EX-23.1 618
  Complete submission text file 0000912057-01-531901.txt   245618
Mailing Address 617 LUSK BLVD SAN DIEGO CA 92121
Business Address 6175 LUSK BLVD SAN DIEGO CA 92121 8584105200
ALLIANCE PHARMACEUTICAL CORP (Filer) CIK: 0000736994 (see all company filings)

EIN.: 141644018 | State of Incorp.: NY | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12950 | Film No.: 1735280
SIC: 2835 In Vitro & In Vivo Diagnostic Substances